Analyst ratings
Across 2 analysts the consensus is a Strong Buy: 2 buy calls against 0 sell, with an average 12-month price target of $32.50.
NASDAQ: SLS · Biotechnology
Over the past week, SELLAS Life Sciences Group (SLS) logged about 329 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 24% bullish but is deeply split: X runs 48% bullish while News sits at just 0%. Wall Street is more constructive, with 2 of 2 analysts rating SLS a buy.
There is steady buzz around SLS this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 0% to X at 48%. No other tracker puts the two side by side.
Across 2 analysts the consensus is a Strong Buy: 2 buy calls against 0 sell, with an average 12-month price target of $32.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 76 points above the crowd average of 24%, the professionals are more constructive than retail. The split is inside the crowd: X reads 48% bullish while News sits at 0%, a 48-point spread that single-source trackers miss.
Over the 30-day window, SELLAS Life Sciences Group (SLS) buzz held elevated around 65.6 while the price drifted up 0.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 6M shares. Updated Oct 10, 2026. Over the last 7 trading days, SLS gained 2.8%. Buzz activity in the recent week averaged 57.1 and was variable, swinging between 46.8 and 66.9. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 15 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for SLS and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SLS sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (2 / 0 / 0) |
| Crowd bullish (7d) | 24% |
| Avg price target | $32.50 |
| Most bullish source | X, 48% |
| Most bearish source | News, 0% |
| Sentiment spread | 48 pts |
| Mentions (7d) | 329 |
| Market cap | $2.35B |
| EPS · Beta | -$0.21 · 2.6 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, SELLAS Life Sciences Group (SLS) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 24% bullish across 3 active sources. Those sources contribute 329 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around SELLAS Life Sciences Group (SLS) is moderately active with 151 mentions over the last 7 days; the 30-day context spans 23 tracked subreddits. The 7-day tone is 23% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on SELLAS Life Sciences Group (SLS), averaging 24% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 48% bullish and News at 0%, a 48-point spread. On the professional side, 2 of 2 analysts rate SLS a buy.
Of the 2 analysts covering SELLAS Life Sciences Group (SLS), 2 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $32.50. That puts the street ahead of the crowd, which averages 24% bullish.
SELLAS Life Sciences Group (SLS)'s cross-source average is bearish at 24% bullish. All 3 tracked sources lean bearish. Reddit reads 23% bullish, X reads 48% bullish and news coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for SELLAS Life Sciences Group (SLS) at 24% bullish. All 3 tracked sources lean bearish. The most bearish reading is news at 0% bullish. 3-day activity momentum is falling across Reddit and X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 174 mentions (53% of total volume). Reddit contributes 151 mentions and News contributes 4 mentions. The cross-source average is bearish at 24% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SLS's sell signal at 93/100 conviction reflects a bearish cross-source average at 24% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The SLS sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key